Methocarbomal Granules Dc 90% Powder
NDC Package 62207-705-04

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Methocarbomal Granules Dc 90% powders is methocarbamol is used to treat muscle spasms/pain. This formulation utilizes a powder delivery system. Marketed by Granules India Limited, this product is identified by NDC 62207-705.

Identification & Billing

NDC Package Code
62207-705-04
Package Description
5000000 mg in 1 DRUM
Product Code
62207-705
11-Digit Billing Format
62207070504

Clinical Specifications

Proprietary Name
Methocarbomal Granules Dc 90%
Non-Proprietary Name
Methocarbomal Granules Dc 90%
Substance Name
Methocarbamol
Dosage Form
Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
Active Ingredient(s)
METHOCARBAMOL 90 mg/100mg
Usage Information
Methocarbamol is used to treat muscle spasms/pain. It is usually used along with rest, physical therapy, and other treatment. It works by helping to relax the muscles.

Regulatory & Marketing

Labeler Name
Granules India Limited
Product Type
Drug For Further Processing
Marketing Category
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date
11-15-2019
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (62207-705). Click a package code to view its specific billing and regulatory data.

62207-705-13
5000000 mg in 1 DRUM

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 62207-705-04 identifies a specific commercial package of 5000000 mg in 1 drum of Methocarbomal Granules Dc 90% (UNFINISHED drug), drug for further processing labeled by Granules India Limited. This powder is formulated for use and contains methocarbamol as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Granules India Limited on November 15, 2019. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Methocarbamol is used to treat muscle spasms/pain. It is usually used along with rest, physical therapy, and other treatment. It works by helping to relax the muscles.

How is this Granules India Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 62207070504. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
62207-705-04
11-Digit CMS (5-4-2)
62207-0705-04

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.